The role of angiotensin II type 1 receptor-activating antibodies in patients with lupus nephritis

International Journal of Clinical Practice

Volumn 67, Issue 10, 2013, Pages 1066-1067

  Xiong, J ^a   Liang, Y ^b   Yang, H ^a   Zhu, F ^a   Wang, Y ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b General Military Hospital of Guangzhou   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II TYPE 1 RECEPTOR ACTIVATING ANTIBODY; AUTOANTIBODY; GLOBULIN; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; BLOOD PRESSURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; GLOBULIN BLOOD LEVEL; HUMAN; LETTER; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETROSPECTIVE STUDY; UPREGULATION;

ANTIBODIES; ANTIBODIES, ANTICARDIOLIPIN; CASE-CONTROL STUDIES; DNA; HUMANS; LUPUS NEPHRITIS; RECEPTOR, ANGIOTENSIN, TYPE 1; RETROSPECTIVE STUDIES;

EID: 84884916364     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12242     Document Type: Letter

References (4)

1. Wallukat G, Homuth V, Fischer T, et al. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 1999; 103: 945-52.
2. Liao YH, Wei YM, Wang M, et al. Autoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertension. Hypertens Res 2002; 25: 641-6.
3. Dragun D, Brasen JH, Schonemann C, et al. Patients with steroid refractory acute vascular rejection develop agonistic antibodies targeting angiotensin II type 1 receptor. Transplant Proc 2003; 35: 2104-5.
4. Dragun D, Müller DN, Bräsen JH, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352: 558-69.